QuidelOrtho is dedicated to the development and production of innovative technologies aimed at enhancing the performance of diagnostic testing and improving patient outcomes across the entire healthcare continuum. Ranked among the world’s largest in vitro diagnostics (IVD) providers, QuidelOrtho is leveraging over 120 years of collective experience and innovation. The company integrates industry-leading expertise in immunoassay and molecular testing with a global presence in point-of-care settings, clinical labs, and transfusion medicine to propel essential diagnostic solutions on a large scale.